The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer

OBJECTIVE: HER2 overexpression is associated with aggressive phenotypes in breast cancer, including increased tumor proliferation, greater invasiveness, and reduced overall survival. The overall response rate to HER2-targeted therapies remains <30%. There is an urgent need for the identification...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xuelu, Song, Chen, Huang, Gena, Sun, Siwen, Qiao, Jingjing, Zhao, Jinbo, Zhao, Zuowei, Li, Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367898/
https://www.ncbi.nlm.nih.gov/pubmed/28356761
http://dx.doi.org/10.2147/OTT.S132806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367898/
https://www.ncbi.nlm.nih.gov/pubmed/28356761
http://dx.doi.org/10.2147/OTT.S132806

Ejemplares similares